FDA approves AstraZeneca’s Calquence for untreated mantle cell lymphoma By Investing.com
Investing.com -- AstraZeneca (LON:) in a inventory alternate submitting on Friday stated that the FDA accredited its drug Calquence (acalabrutinib) ...
Tuesday, April 22, 2025
Tag: AstraZenecas
Why AstraZeneca’s Gracell Biotechnologies Acquisition Is A Win-Win (NASDAQ:GRCL)
Tippapatt China's biotech company Gracell Biotechnologies Inc. (NASDAQ:GRCL) is ending the year with quite the bang, having seen an almost ...
AstraZeneca’s Imfinzi, Lynparza cuts risk of uterus cancer progression in phase 3 trial
Fotonen/iStock Editorial via Getty Images AstraZeneca (NASDAQ:AZN) said Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival (PFS) ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.